Laboratory-generated mini-kidneys help understand the link between diabetes and COVID-19 disease
Researchers from Hospital Clínic-IDIBAPS have participated in an international collaboration led by IBEC in which they have generated human mini-kidn1
Service News from The Nephrology and Renal Transplant Service
9 transplants in 48 hours, a real record in times of pandemic
The Hospital Clínic de Barcelona recently performed 9 transplants in under 48 hours. This milestone had never been recorded before at the Hospital an1
For the first time, the Hospital Clínic performs 1,000 apheresis procedures in one year
The Apheresis Unit, established in 1980, and which recently opened a new room, has achieved this milestone for the first time since its creation.
The Hospital Clínic applies patient experience as a strategic challenge in kidney-pancreas transplantation
The Hospital Clínic Nephrology and Urology Institute (ICNU) is working to introduce a new, patient-centred healthcare model: patient experience (XPA)1
Researchers at the Hospital Clínic-IDIBAPS predict with an accuracy of 96% the evolution of kidney transplant patients admitted to hospital with COVID-19
Researchers from the Hospital Clínic-IDIBAPS coordinated a study that made it possible to determine with an accuracy of 96% whether a kidney transpla1
2 out of 3 kidney transplant patients are immune to COVID-19 after vaccination
A study published by the American Journal of Transplantation and led by researchers from the Hospital Clínic-IDIBAPS states that 65% of all patients1
The Hospital Clínic, the first hospital in Spain to carry out 1,000 living donor kidney transplants
The Hospital Clínic de Barcelona has become the first hospital in Spain to carry out over 1,000 living donor kidney transplants. To mark this milesto1
What is the quality of life of kidney donors after one year?
The majority of kidney donors believe that it was worth going through the process of donation, and would repeat it if necessary. This study, coor1
Treatment with tocilizumab in patients with kidney transplant reduces mortality from COVID-19
In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammat1
New technique to identify a cause that is common to diseases related to thrombotic microangiopathies for which there is a treatment
Researchers of the Hospital Clínic-IDIBAPS and the Josep Carreras Leukemia Research Institute have developed a new technique that allows detecting an1